Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
3,902.00    -68.00 (-1.71%)
Bid:
3,904.00
Ask:
3,908.00
Spread: 4.00 (0.102%)
Market Cap: £14.74b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Acquisition

23 Jan 2013 09:00

RNS Number : 1738W
Halma PLC
23 January 2013
 



Halma plc ('Halma')

 

ACQUISITION OF BAODING LONGER PUMP

 

 

Halma, the leading safety, health and environmental technology group announces the completion on 23 January 2013 of the acquisition of Thinketron Precision Equipment Company Limited ('TPE') based in Hong Kong and its subsidiaries Baoding Longer Precision Pump Co., Ltd ('Longer Pump') based in China and Langer Instruments Corporation ('LIC') based in the USA.

 

Longer Pump manufactures and markets peristaltic, syringe and gear pumps used in laboratory, medical and industrial applications. LIC is Longer Pump's distributor in the USA.

 

The initial cash consideration was RMB 237 million (£23.7 million) for the share capital of TPE. Deferred consideration of RMB 3 million (£0.3 million), which is adjustable RMB for RMB if the net tangible asset value (NTAV) is over/under a targeted amount, is payable upon agreement of the NTAV. The targeted NTAV includes approximately RMB 22.5 million (£2.25 million) of cash.

 

Unaudited accounts for the year ended 31 December 2012 show adjusted operating profit of RMB 23.5 million (£2.35 million). Audited accounts for the year ended 31 December 2011 show adjusted operating profit of RMB 18.2 million (£1.82 million).

 

Existing management of Longer Pump and LIC will remain in place and will continue to operate the business supported by new Board members appointed from within Halma China. The acquisition, which is expected to be immediately earnings enhancing, has been funded from Halma's cash and debt facilities.

 

Longer Pump will join Halma's Health & Analysis sector within the Fluid Technology sub-sector adding complementary high-value fluid handling products which are sold through a large sales network in China. Approximately 80% of Longer Pump's revenue is generated from China.

 

 

Andrew Williams, Halma's Chief Executive, commented:

 

"Longer Pump's alignment with Halma's growth drivers is strong. Sales of their products are driven by increasing demand for healthcare and healthcare research, as well as the urbanisation and industrialisation within China. Their significant local market knowledge and technical resources will help our Fluid Technology sub-sector accelerate growth in this important region.

 

There are also opportunities for Halma to contribute to the growth of Longer Pump, utilising both the network of regional hub offices which Halma has established within China and the worldwide reach of our Fluid Technology businesses."

 

 

 

 

For further information please contact:

 

Halma plc

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

 

 

 

+44 (0)1494 721111

MHP Communications

Rachel Hirst/Andrew Jaques

+44 (0)20 3128 8100

 

Notes

 

1.

Exchange rate used: RMB 10/£1.

 

2.

Longer Pump has been specialising in the manufacture of peristaltic pumps, syringe pumps, gear pumps and pump accessories for 15 years. It has significant IP and R&D capabilities with sales to a diverse, mainly non-OEM, customer base.

 

Peristaltic pumps provide reliable solutions for demanding fluid handling applications in the laboratory, industrial and OEM markets.

 

Growth prospects in their core geographic market of China for peristaltic pumps are strong. One industry forecast expects market growth of approximately 12% for the next several years, before increasing to over 20% in 2016.

 

3.

Halma buys successful businesses in safety, health and environmental markets and helps them grow further through investment targeted towards increasing innovation, management development and international expansion. In the past 10 years Halma has spent approximately £400m acquiring 30 businesses with deal sizes ranging from £70m down to below £1m. Although businesses have been acquired in all areas of our activity, the majority of recent acquisitions has been in the Health & Analysis Sector.

 

4.

This statement is not intended to constitute a profit forecast for the current financial period or for any future period. In addition, this statement should not be taken to mean that the earnings per share of Halma will necessarily match or exceed the historic reported earnings per share of Halma.

 

5.

A copy of this announcement, together with other information about Halma and its Fluid Technology businesses, may be viewed on our website: www.halma.com.

 

6.

Halma's next Interim Management Statement will be issued on 14 February 2013.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQBJMPTMBATMJJ
Date   Source Headline
14th May 201210:55 amRNSHolding(s) in Company
11th May 20123:15 pmRNSHolding(s) in Company
2nd May 20123:48 pmRNSTotal Voting Rights
1st May 20126:22 pmRNSTreasury Stock
2nd Apr 201210:20 amRNSTotal Voting Rights
1st Mar 201210:24 amRNSTotal Voting Rights
28th Feb 20127:00 amRNSChange of Adviser
23rd Feb 20122:15 pmRNSDirector/PDMR Shareholding
21st Feb 20123:08 pmRNSAdditional Listing
16th Feb 20127:00 amRNSInterim Management Statement
10th Feb 20129:38 amRNSTreasury Stock
9th Feb 201211:33 amRNSTreasury Stock
8th Feb 201210:32 amRNSTreasury Stock
3rd Feb 201212:22 pmRNSTreasury Stock
2nd Feb 20122:56 pmRNSTotal Voting Rights
24th Jan 20124:42 pmRNSBlocklisting Interim Review
3rd Jan 20124:57 pmRNSTotal Voting Rights
1st Dec 20114:40 pmRNSTotal Voting Rights
22nd Nov 20112:25 pmRNSDoc re. Half Year Report 2011/12
22nd Nov 20117:00 amRNSHalf Yearly Report
21st Nov 201111:08 amRNSDirector Declaration
14th Nov 20113:46 pmRNSHolding(s) in Company
14th Nov 20113:44 pmRNSNotice of Results
11th Nov 20117:00 amRNSDirectorate Change
2nd Nov 201112:56 pmRNSDirector Declaration
1st Nov 201111:12 amRNSTotal Voting Rights
17th Oct 20114:06 pmRNSHolding(s) in Company
11th Oct 20113:35 pmRNSHolding(s) in Company
6th Oct 20112:54 pmRNSDirector/PDMR Shareholding
3rd Oct 201110:41 amRNSTotal Voting Rights
15th Sep 201112:47 pmRNSDirector/PDMR Shareholding
1st Sep 201112:47 pmRNSTotal Voting Rights
26th Aug 20112:32 pmRNSBlocklisting Interim Review
16th Aug 20115:19 pmRNSAnnual Information Update
12th Aug 20114:43 pmRNSShare transactions and Purchase of Own Shares
8th Aug 201112:48 pmRNSTreasury Stock
1st Aug 20112:40 pmRNSTotal Voting Rights
29th Jul 20112:10 pmRNSDirectorate Change
29th Jul 20111:20 pmRNSResult of AGM
28th Jul 20117:00 amRNSAGM Statement
12th Jul 201110:13 amRNSDirector/PDMR Shareholding
11th Jul 20119:25 amRNSAcquisition
1st Jul 201111:55 amRNSTotal Voting Rights
28th Jun 20114:06 pmRNSDirector/PDMR Shareholding
27th Jun 201112:45 pmRNSAnnual Financial Report
21st Jun 20117:00 amRNSFinal Results
14th Jun 20119:24 amRNSNotice of Results
2nd Jun 201111:51 amRNSTotal Voting Rights
10th May 20119:00 amRNSAcquisition
5th May 201112:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.